# Safety of CRIS100 on Treatment Spinal Cord Injury

> **NCT05739734** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Cristália Produtos Químicos Farmacêuticos Ltda.** · enrollment: 5 (estimated)

## Conditions studied

- Thoracic Spinal Cord Injury

## Interventions

- **DRUG:** CRIS100

## Key facts

- **NCT ID:** NCT05739734
- **Lead sponsor:** Cristália Produtos Químicos Farmacêuticos Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05739734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05739734, "Safety of CRIS100 on Treatment Spinal Cord Injury". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05739734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*